EGFR mutation also induces upregulation of MDSCs, increases IDO in DCs, and enhances M2-like polarization and migration of TAMs, which abrogates CD8+ T cell and cytotoxic NK cell-mediated tumor killing. The gene discussed is EGFR; the disease is neoplasm.